Skip to content

Clinical trials

Completed Neurotoxicity Syndromes trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurotoxicity Syndromes Phase: Not applicable Status: Completed Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20101
20141
20171
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Case Comprehensive Cancer Center1
Massachusetts General Hospital1
Ministry of Public Health, Democratic Republic of the Congo1
Nantes University Hospital1
National Cancer Institute (NCI)1
Universidad de Granada1
University Hospital, Montpellier1
University of Zurich1
Virginia Commonwealth University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurotoxicity Syndromes9
Amphetamine-Related Disorders1
Breast Neoplasms1
Cytokine Release Syndrome1
Lymphoma, B-Cell1
Pain1
Peripheral Nervous System Diseases1
Stomach Neoplasms1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.